Truist Financial Corp Artivion, Inc. Transaction History
Truist Financial Corp
- $66.7 Billion
- Q2 2025
A detailed history of Truist Financial Corp transactions in Artivion, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 17,703 shares of AORT stock, worth $724,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,703Holding current value
$724,937% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
185Shares Held
38.7MCall Options Held
19.5KPut Options Held
2.5K-
Black Rock Inc. New York, NY6.64MShares$272 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.9MShares$119 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$115 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$114 Million2.87% of portfolio
-
Morgan Stanley New York, NY2.26MShares$92.6 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.65B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...